⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 18, 2024United European Gastroenterology JournalOpen Access

Fibroblast growth factor 21 is a hepatokine involved in MASLD progression

Rocío Gallego‐Durán Javier Ampuero Douglas Maya‐Miles Helena Pastor‐Ramírez Rocío Montero‐Vallejo Jesús Rivera‐Esteban Leticia Álvarez‐Amor María Jesús Pareja María Carmen Rico Raquel Millán María José Robles‐Frías R. Aller Ángela Rojas Rocío Múñoz‐Hernández Antonio Gil‐Gómez Sheila Gato María del Rosario García-Lozano M. Arias Javier Abad José Luís Calleja Raúl J. Andrade Javier Crespo Águeda González‐Rodríguez Carmelo García‐Monzón Fausto Andreola Juan M. Pericàs Rajiv Jalan Franz Martı́n Manuel Romero‐Gómez

View Full Paper

Ask AI

Bookmark

Share

Abstract

We aimed to assess the role of FGF21 in metabolic dysfunction-associated steatotic liver disease (MASLD) at a multi-scale level.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gallego‐Durán et al. (2024) studied this question.

synapsesocial.com/papers/68e642a9b6db6435875d4b46 https://doi.org/10.1002/ueg2.12534

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1FGF21 Analogues and MASLD: A Summary of Preclinical and Clinical Data2025 · 9 citations
2Fibroblast Growth Factor 21: Mechanisms, Therapeutic Potential, and Clinical Translation in Metabolic DysfunctionLate-Phase Clinical Trial · 2026 · 5 citations
3Role of serum FGF21 in the diagnosis of metabolic dysfunction–associated fatty liver disease: a case–control study of Egyptian patients2025
4Role of Serum FGF21 in the diagnosis of Metabolic dysfunction–Associated Fatty Liver Disease: A Case-Control Study of Egyptian patients2025
52465-P: FGF21 Is Related to Insulin Secretion during OGTT in Patients with High MASLD Probability: Preliminary Data from a Human CohortOriginal Research · 2026